Filing Details

Accession Number:
0001209191-19-002796
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-08 16:37:33
Reporting Period:
2019-01-04
Accepted Time:
2019-01-08 16:37:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236934 J Paula Swain 1801 Augustine Cut-Off
Wilmington DE 19803
Evp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-01-04 30,000 $18.32 62,324 No 4 M Direct
Common Stock Disposition 2019-01-04 30,000 $70.00 32,324 No 4 S Direct
Common Stock Disposition 2019-01-07 1,200 $74.21 31,124 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Acquisiton 2019-01-04 22,772 $0.00 22,772 $72.27
Common Stock Employee Stock Option (right to buy) Acquisiton 2019-01-04 31,552 $0.00 31,552 $72.27
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2019-01-04 30,000 $0.00 30,000 $18.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
22,772 2029-01-03 No 4 A Direct
31,552 2029-01-03 No 4 A Direct
21,782 2020-02-08 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
  2. Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock.
  3. This includes an aggregate of 5,416 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
  4. Beginning January 4, 2019, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2019 and the remainder vesting monthly over three years.
  5. Beginning January 4, 2019, options become exercisable in full on January 4, 2023.
  6. Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.